QTTB Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
-100.0%
53.7M
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
-100.0%
53.7M
0
0
Operating Expenses
9.1M
+18.1%
7.7M
-1.7%
7.9M
+3.7%
7.6M
-17.4%
9.2M
R&D
4.3M
+32.3%
3.2M
-2.9%
3.3M
-6.8%
3.6M
-31.1%
5.2M
SG&A
4.9M
+7.9%
4.5M
-0.9%
4.5M
+13.0%
4.0M
+0.3%
4.0M
Operating Income
-9118000
-18.1%
-7722000
-116.8%
45.9M
+705.5%
-7577000
+17.4%
-9171000
EBITDA
-9033000
-18.4%
-7632000
-116.6%
46.0M
+714.1%
-7486000
+17.6%
-9080000
Net Income
-8946000
-17.6%
-7609000
-113.2%
57.7M
+881.3%
-7389000
+22.1%
-9489000
EPS (Basic)
$-0.44
+18.5%
$-0.54
-111.8%
$4.59
+865.0%
$-0.60
+23.1%
$-0.78
EPS (Diluted)
$-0.44
+18.5%
$-0.54
-111.8%
$4.57
+861.7%
$-0.60
+23.1%
$-0.78
Shares (Diluted)
20.3M
+44.3%
14.1M
+11.7%
12.6M
+3.1%
12.2M
+0.4%
12.2M
Q32 Bio (QTTB) โ€” Financials